IPSEN BIOPHARMACEUTICALS
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated .
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under IPSEN BIOPHARMACEUTICALS.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Ipsen Biopharmaceuticals, Inc.. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 61 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · EVP, PRESIDENT NORTH AMERICA · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · ASSOCIATE VP, GOVERNMENT AFFAIRS & POL · 25 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · SENIOR NEUROSCIENCE SPECIALTY REPRESEN · 25 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · SVP, NA GENERAL COUNSEL · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · DIR, STATE GOVERNMENT AFFAIRS & POLICY · 24 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CONSHOHOCKEN, PA, 19428 · IPSEN BIOPHARMACEUTICALS · Healthcare & Pharmaceuticals · SENIOR VICE PRESIDENT · 4 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · ASSOCIATE DIRECTOR, FIELD HEOR · 23 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · SENIOR VICE PRESIDENT, VALUE & ACCESS · 22 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · HEAD OF BUSINESS ETHICS · 22 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02142 · IPSEN BIOPHARMACEUTICALS INC. · Healthcare & Pharmaceuticals · EXECUTIVE STRATEGIC ACCOUNT DIRECTOR · 21 transaction rows
Where the contributions went · 10 per page
Showing 1–2 of 2 · largest absolute amount first
PAC (qualified) · CAMBRIDGE, MA · 700 transaction rows
House campaign committee · SOMERVILLE, NJ · BENNETT, REBECCA · U.S. House NJ 07 · 4 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Reported as IPSEN BIOPHARMACEUTICALS
Industry classification summary
Ipsen Biopharmaceuticals, Inc. is the US subsidiary of Ipsen, a global biopharmaceutical company focusing on oncology, rare diseases, and neuroscience. The research confirms its official website and industry through its parent, its industry as a pharmaceutical company.
AI-generated classification based on saved sources
View source